A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation
ACS Chemical Biology · 2024
DOI: 10.1021/acschembio.4c00354 ↗Kurz gefasst
Leserbrief in der Zeitschrift ACS Chemical Biology, 2024. Verfasst von Chiaki T Ishida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology, Johns Hopkins University, Baltimore, Maryland 21205 United States. Hauptthemen laut MEDLINE: High-Throughput Screening Assays, Sterol Regulatory Element Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology, Johns Hopkins University, Baltimore, Maryland 21205 United States.
- Johns Hopkins Drug Discovery and Department of Neurology, Johns Hopkins University, Baltimore, Maryland 21205 United States.
- Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University,Baltimore, Maryland 21205 United States.
- Giovanis Institute for Translational Cell Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 United States.
ORCID-Profile: Chiaki T Ishida, Casie S Kubota, Takashi Tsukamoto
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- National Cancer Institute
- Division of Graduate Education
- National Institute of General Medical Sciences
Zitieren
APA
T Ishida, C., Kubota, C. S., Carlyle, E., Tsukamoto, T., & Espenshade, P. J. (2024). A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00354
Vancouver
T Ishida C, Kubota CS, Carlyle E, Tsukamoto T, Espenshade PJ. A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00354
BibTeX
@article{TIshida2024,
author = {T Ishida, Chiaki and Kubota, Casie S and Carlyle, Evan and Tsukamoto, Takashi and Espenshade, Peter J},
title = {A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation},
journal = {ACS Chemical Biology},
year = {2024},
doi = {10.1021/acschembio.4c00354}
}
EUVIMED